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Circulation
ORIGINAL RESEARCH ARTICLE

Gata4-Dependent Differentiation of
c-Kit+–Derived Endothelial Cells Underlies
Artefactual Cardiomyocyte Regeneration
in the Heart
BACKGROUND: Although c-Kit+ adult progenitor cells were initially
reported to produce new cardiomyocytes in the heart, recent genetic
evidence suggests that such events are exceedingly rare. However, to
determine if these rare events represent true de novo cardiomyocyte
formation, we deleted the necessary cardiogenic transcription factors
Gata4 and Gata6 from c-Kit–expressing cardiac progenitor cells.
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METHODS: Kit allele–dependent lineage tracing and fusion analysis
were performed in mice following simultaneous Gata4 and Gata6 cell
type–specific deletion to examine rates of putative de novo cardiomyocyte
formation from c-Kit+ cells. Bone marrow transplantation experiments
were used to define the contribution of Kit allele–derived hematopoietic
cells versus Kit lineage–dependent cells endogenous to the heart in
contributing to apparent de novo lineage-traced cardiomyocytes. A
Tie2CreERT2 transgene was also used to examine the global impact of Gata4
deletion on the mature cardiac endothelial cell network, which was
further evaluated with select angiogenesis assays.
RESULTS: Deletion of Gata4 in Kit lineage–derived endothelial cells or in
total endothelial cells using the Tie2CreERT2 transgene, but not from bone
morrow cells, resulted in profound endothelial cell expansion, defective
endothelial cell differentiation, leukocyte infiltration into the heart, and a
dramatic increase in Kit allele–dependent lineage-traced cardiomyocytes.
However, this increase in labeled cardiomyocytes was an artefact of
greater leukocyte-cardiomyocyte cellular fusion because of defective
endothelial cell differentiation in the absence of Gata4.
CONCLUSIONS: Past identification of presumed de novo cardiomyocyte
formation in the heart from c-Kit+ cells using Kit allele lineage
tracing appears to be an artefact of labeled leukocyte fusion with
cardiomyocytes. Deletion of Gata4 from c-Kit+ endothelial progenitor cells
or adult endothelial cells negatively impacted angiogenesis and capillary
network integrity.
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What Is New?
• This is the first study to genetically delete the necessary cardiogenic transcription factors Gata4/6
from c-Kit+ cardiac progenitor cells, which remarkably resulted in greater apparent cardiomyocyte
derivation from these c-Kit+ cells.
• Deletion of Gata4 from c-Kit–derived endothelial
progenitors alters the integrity of the endothelial
cell network in the heart, resulting in more c-Kit+–
derived leukocytes entering the heart and fusing
with cardiomyocytes.
• We demonstrate a new role for Gata4 in endothelial differentiation, specifically showing for the first
time that Gata4 is essential for vascular development via the c-Kit lineage.
• This study shows that leukocyte-to-cardiomyocyte
fusion is the primary basis for past lineage-tracing
results incorrectly suggesting that c-Kit+ cardiac
progenitor cells generated de novo cardiomyocytes
in the heart.

What Are the Clinical Implications?
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• Our data demonstrate that c-Kit+ cardiac progenitor cells are much less likely to differentiate de
novo into cardiomyocytes than previously reported,
suggesting that such cells are not therapeutically
meaningful as a source of new cardiomyocytes.
• Our study highlights a capillary-driven mechanism of
increased fusion of bone marrow–derived cells (leukocytes) with existing cardiomyocytes, which could
have significant clinical implications in its own right.
• Kit lineage and global endothelial cell deletion of
Gata4 reveal apparent organ-specific regulation of
microvascular differentiation, highlighting Gata4
as a potential target for angiogenic control in the
human heart.

L

arge-scale cardiomyocyte loss from a cardiac ischemic event initially elicits a dramatic inflammatory
response, followed by fibroblast activation with scar
formation and fibrosis, and then ventricular remodeling
and eventually heart failure.1 To combat this profile of
progressive cardiac deterioration after ischemic injury,
cell-specific approaches have emerged with emphasis
on altering the hematopoietic response,2 ameliorating fibrotic remodeling,3–6 increasing collateral circulation,7,8 and preserving or replacing cardiomyocytes.9,10
Earlier reports that endogenous cardiac stem cells exist
and might be efficacious in mediating cardiac regeneration generated a great deal of excitement in the
field.11,12 c-Kit+ cardiac progenitor cells (CPCs), named
for the presence of c-Kit tyrosine kinase receptor that
marks hematopoietic stem cells,13 have been the focus
of numerous cardiac regenerative studies.14–16 Select
Circulation. 2018;138:1012–1024. DOI: 10.1161/CIRCULATIONAHA.118.033703

METHODS
An expanded Methods section is available in the online-only
Data Supplement.
The data, analytic methods, and study materials will be
made available to other researchers for purposes of reproducing the results or replicating the procedure by contacting
the corresponding author. The RNA sequencing data were
deposited with the GEO database group and given accession
number GSE109661.

Animals
All experiments involving mice were approved by the
Institutional Animal Care and Use Committee at Cincinnati
September 4, 2018
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clinical trials evaluating the administration of bone marrow cells after myocardial infarction have shown minimal efficacy.17–19 However, expanded cardiac c-Kit+ cells
were reported to potentially impart greater functional
benefit with scar reduction when administered to patients post–myocardial infarction injury.20,21
Although injection of exogenously expanded CPCs
may indeed positively impact the myocardial infarction–
injured heart, several recent studies have definitively
shown that the heart lacks an endogenous c-Kit+ CPC
capable of producing new cardiomyocytes in vivo.22–24
For example, we determined that endothelial cells are
the major fate of Kit lineage–traced cells in the heart and
that only 1 in 17 000 cardiomyocytes might be produced
de novo when an 80% fusion rate is taken into account.22
Sultana and colleagues23 confirmed these results, demonstrating that a large proportion of lineage-traced Kit
allele–derived cells are endothelial, whereas Kit allele
lineage–traced cardiomyocytes coexpressing cardiac troponin T in the adult mouse heart were exceptionally rare.
Furthermore, a novel Cre/Dre dual recombinase mouse
genetic system by He and colleagues,24 which no longer
relies on the heterozygosity of the Kit allele, showed that
c-Kit+ cells never produce de novo cardiomyocytes in the
adult heart at baseline or with injury. However, the potential to genetically reprogram c-Kit–derived cells and
other cardiac mesenchymal cells into cardiomyocytes remains attractive for future development.25,26
The goal of the current study was to determine the
contribution of true versus apparent Kit allele lineage–
derived cardiomyocytes by simultaneously deleting
the cardiomyogenic transcription factors Gata4 and
Gata6, which, when deleted from mesodermal progenitors during early development, results in acardia
and absence of cardiomyocytes.27 We report here that
deletion of Gata4 from c-Kit+ cells preferentially impacted a population of c-Kit–expressing endothelial
cells and their differentiation state, resulting in defective cardiac capillary formation and immune cell infiltration, which secondarily resulted in a dramatically
enhanced rate of fusion of c-Kit–derived immune cells
with cardiomyocytes.
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Children’s Hospital Medical Center. Kit-Cre recombinase
knock-in mice (KitCre) and Kit mice with a knock-in of the
tamoxifen-inducible MerCreMer cDNA (KitMCM), and Rosa26
lineage-dependent reporter mice, as well, were each previously described.22 LoxP-targeted Gata4 (Gata4fl) and Gata6
(Gata6fl) mice were described previously.28,29 The endothelial
specific Tie2CreERT2 transgenic mouse model was described
elsewhere (Y. Zheng and colleagues, unpublished data).29a
Detailed descriptions of tamoxifen-dosing procedures and
euthanasia procedures are provided in the online-only Data
Supplement.

Protein Analysis
Immunofluorescent stains were performed on cryoembedded
tissues,22 and Western blots were performed on cells isolated
by fluorescence-activated cell sorting and whole cardiac ventricle tissue as described previously.30 Descriptions of the antibodies used are provided in the online-only Data Supplement.

Gata4-Dependent Endothelial Differentiation

RNA Sequencing Analysis
Endothelial cells were collected as described above for RNA
harvest and production of cDNA libraries for sequencing.
Libraries were sequenced on the Illumina HiSeq2500 following the manufacturer’s protocol. Selected genes were verified
by quantitative polymerase chain reaction.

Statistics
See Methods in the online-only Data Supplement for an indepth description of statistics.

RESULTS
Kit Lineage-Specific Gata4-, Gata6-, and
Gata4/6-Deleted Mice

Cells were prepared for flow cytometry studies on cardiac
interstitial cells and BMCs as described in detail before.4,22,32
BMCs and cardiac interstitial cells were stained with surface markers using allophycocyanin-conjugated antibodies,
and optimum gating strategy was determined using singly
labeled controls.

To examine the hypothesis that the deletion of Gata4
and Gata6 from c-Kit+ CPCs in the heart would block
all de novo cardiomyocyte formation, we crossed KitMCM
mice with mice containing loxP site (fl)–targeted alleles for Gata4 and Gata6 (Figure 1A). Again, loss of
both transcription factors should lead to the inability
of CPCs to activate the cardiac transcriptional program
required for cardiogenesis.27,33,34 In addition, mice were
bred to harbor either the Rosa26-loxP-stop-loxP-eGFP
(R26eGFP) allele or the Rosa26-membrane-Tomato-loxPStop-loxP-membrane-eGFP allele35 (R26mT/mG) to trace
total Kit allele–derived cells in the heart and to examine
fusion-derived cardiomyocytes, respectively (Figure 1A).
Fusion is scored when both the m-eGFP and m-Tomato
signals are observed in the same cardiomyocyte, whereas a de novo transdifferentiation event from a c-Kit+
CPC would give cardiomyocytes that are only m-eGFP
positive. After weaning, mice were put on tamoxifen
food for continuous labeling of Kit lineage–derived
cells (Figure 1B). Recombination of these loxP-targeted
alleles was assessed by polymerase chain reaction on
control and tamoxifen-treated mice, showing specific
recombination (Figure 1C). Mice were euthanized after
1, 2, and 4 months of tamoxifen treatment for histological and flow cytometry analysis of heart and other
tissues. Unexpectedly, total eGFP+ cardiomyocytes were
increased in mice with deletion of Gata4/6 or Gata4,
but not Gata6 alone with ≈2-fold, 4-fold, and 10-fold
increases at 1, 2, and 4 months, respectively (Figure 1D
through 1F). Dual reporter labeling in Gata4/6- and
Gata4-deleted mice revealed significantly more fusionderived cardiomyocytes (91%–93%) versus 80% to
83% in KitMCM R26mT/mG controls (Figure 1G and 1H). It
is interesting to note that skeletal muscle showed the
appearance of eGFP+-fused myofibers in Gata4/6- and
Gata4-deleted Kit-lineage mice for the first time (Figure
I in the online-only Data Supplement), whereas other
known immune cell–based fusion-prone tissues such
as the liver36,37 did not (data not shown). These results
collectively show that deletion of Gata4 from Kit allele–
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Vascular Endothelial Growth Factor-A
Overexpression
An adeno-associated virus-9 vector expressing VEGF-A (vascular endothelial growth factor-A) was prepared and titered
(online-only Data Supplement Methods). Adult C57Bl/6 mice
were administered adeno-associated virus-9–VEGF-A by tail
vein injection at concentration of 1×1012 viral particles in 200
µL of sterile phosphate-buffered saline.

Downloaded from http://ahajournals.org by on January 12, 2022

Bone Marrow Transplantation
Bone marrow transplantations were performed by transplanting bone marrow cells from 6- to 8-week-old donor mice into
8- to 10-week-old recipients. Bone marrow cells (BMCs) were
isolated by aseptically flushing femurs and tibiae with Hanks’
Balanced Salt Solution. Bone marrow transplant recipient
mice first received lethal irradiation (12 Gy in a divided dose 4
hours apart31) and then immediately received a tail vein injection of BMCs at ≈50 million per mouse in 200 µL of Hanks’
Balanced Salt Solution.

Retinal Angiogenesis Assay
To observe the superficial vascular plexus to assess endothelial developmental defects, retinal flat mounts were prepared as described earlier.5 In brief, postnatal day (p) 0 mice
were given intraperitoneal injections of 200 μg tamoxifen
(Sigma T5648; dissolved in 5 μL ethanol and 95 μL peanut
oil) for gene inactivation and Tie2 (Tek gene) lineage tracing.
Neonatal mice were euthanized, their eyes were harvested at
p8 and fixed, and the retinas were dissected and mounted
for qualitative comparison by enhanced green fluorescent
protein (eGFP) fluorescence.

Flow Cytometry and Cell Sorting
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Figure 1. Kit allele-lineage deletion of Gata4/6 and Gata4 alone leads to increased lineage-traced cardiomyocytes attributable to fusion.
A, Genetic models with the indicated alleles in mice that were crossed. B, Experimental design of the protocol used in this figure. C, PCR showing recombination
(recomb) of the Gata4 locus with tamoxifen treatment to activate the MerCreMer protein (n=2) or untreated that did not show recombination (n=1) in KitMCM
Gata4/6fl/fl R26eGFP mice. The analysis used Kit lineage tracing in which eGFP+ bone marrow cells were first collected. D, Immunofluorescent images of cardiac histological sections from Kit allele lineage–traced mice with and without Gata4/6 deletion. Arrows indicate eGFP+ cardiomyocytes. E, Time-course quantification of the
percentage of eGFP+ cardiomyocytes within the entire heart in response to Gata4/6 deletion. Error bars are SEM, n=4 per group (10 sections per heart). *P<0.05
vs. KitMCM R26eGFP at each time point. F, Comparative quantitation of the percentage of eGFP+ cardiomyocytes within the entire mouse heart in response to Gata4,
Gata6, or double Gata4/6 deletion in comparison with Kit lineage tracing controls. Error bars are SEM, n=4 per group (10 sections per heart). *P<0.05 vs. KitMCM
R26eGFP for each genotype. G, Immunofluorescent cardiac histological section showing dual reporter evidence of a fusion-derived mTomato+ mGFP+ cardiomyocyte.
H, Percentage of fusion-derived Kit allele lineage–traced cardiomyocytes (mTomato+mGFP+) vs. presumed de novo cardiomyocytes (only mGFP+). Error bars are
SEM, n=4 per group (10 sections per heart). *P<0.05 vs. KitMCM R26mT/mG for each genotype. eGFP indicates enhanced green fluorescent protein; PCR, polymerase
chain reaction; Tam, tamoxifen; and WT, wild type.

derived cells dramatically enhances the relative rate of
apparent cardiomyocyte de novo formation, which is
potentially attributable to augmented fusion of Kit allele–derived immune cells with tissue parenchymal cells
as previously shown.38,39
Immunofluorescence staining of Gata4 was frequently positive in total aggregates of BMCs, which
is also a known site of c-Kit expression as shown by
lineage tracing from the Kit allele to produce eGFP
expression (Figure 2A). It is interesting to note that
CD133+ endothelial progenitor cells40 from the bone
marrow were dramatically enhanced in Kit allele-lineage Gata4/6–deleted mice in comparison with controls, possibly suggesting a functional role for Gata4 in
endothelial cells (Figure 2B). Indeed, previous lineage
tracing with the KitCre mouse model demonstrated that
cardiac Kit-derived cell populations in the heart comprised 77% endothelial cells (CD31+) and 18% leukocytes (CD45+).22 Western blotting of these populations
for Gata4 protein demonstrated detectable expression
in CD31+ endothelial cells but not in CD45+ leukocytes
or total CD31‒ CD45‒ cardiac interstitial cells, or when
Gata4 was deleted from CD31+ cells using a Tie2CreERT2
transgene (Figure 2C). Flow cytometry analysis for
Circulation. 2018;138:1012–1024. DOI: 10.1161/CIRCULATIONAHA.118.033703

CD45+ cell content in the hearts of Kit-lineage Gata4/6and Gata4-deleted mice after 4 months of tamoxifen
showed a ≈50% increase in leukocytes (Figure 2D and
2F) and a ≈60% increase in CD31+ endothelial cells in
comparison with controls (Figure 2E and 2G). Taken
together, these results show a clear alteration of Kit
allele–derived populations in the heart in the absence
of Gata4, such as a dramatic increase in endothelial and
CD45 cell content.

Bone Marrow Transplant to Identify
Cardiovascular Impact of Kit-Lineage
Gata4/6 Loss
We hypothesized that the increase in relative Kit allele
lineage–traced eGFP+ cardiomyocytes with Gata4/6 deletion was attributable to greater leukocyte activity or
altered endothelial cell function. To test this hypothesis,
we performed a bone marrow transplant that would
isolate the impact of Gata4/6 effects from the hematopoietic compartment. Here, the donating bone marrow
was from KitMCM Gata4/6fl/fl R26eGFP mice (or controls not
deleted for Gata4/6) that had already undergone full recombination with 6 weeks of prior tamoxifen treatment,
September 4, 2018
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Figure 2. Cardiac leukocytes and endothelial cells are increased in Kit lineage Gata4-deleted mice.
A, Immunofluorescent staining of Gata4 (red) and DAPI (blue) in bone marrow cells from KitMCM R26eGFP mice (2 months tamoxifen as control) showing some
overlap of Kit lineage–traced eGFP+ cells with Gata4. B, Flow cytometry plots showing CD133+ endothelial progenitor cells in Kit allele–derived bone marrow cells.
C, Western blot showing relative Gata4 levels in c-Kit lineages such as CD45+ leukocytes, CD31+ endothelial cells, and CD31‒ CD45‒ interstitial cells, or CD31+
cells that were deleted for Gata4 with the Tie2CreERT2 transgene. The positive control was neonatal rat ventricular myocytes (NRVM) loaded at a reduced amount to
show the Gata4 band accurately. Although Gapdh was used as a processing and loading control, this protein is more highly expressed in cardiomyocytes and select
other cell types. D, Immunofluorescent staining of CD45+ (white) and DAPI (blue) in cardiac histological sections. E, Immunofluorescent staining of CD31+ (red)
and DAPI (blue) in cardiac histological sections. F, Relative quantification of cardiac CD45+ cells based on flow cytometry of the interstitial cell fraction from dissociated hearts. Error bars are SEM, n=3 per group. *P<0.05 vs. KitMCM R26eGFP for each genotype. G, Relative quantification of cardiac CD31+ cells based on flow
cytometry from the interstitial cell fraction in dissociated hearts. Error bars are SEM, n=3 per group. *P<0.05 vs. KitMCM R26eGFP for each genotype. DAPI indicates
4ʹ,6-diamidino-2-phenylindole; n.s., nonspecific; SSC-A, side scatter area; and Tam, tamoxifen.

which would produce eGFP+ circulating immune cells and
even endothelial progenitors in recipients (Figure 3A). The
recipient mice were in the R26mT genetic background so
endogenous cells could be parsed from eGFP+ cells. Recipient mice were irradiated, then given the bone marrow
transplant and allowed to reconstitute for 8 weeks (Figure 3A). Full bone marrow niche reconstitution was confirmed with Kit-lineage R26eGFP recombination (Figure 3B)
and a general lack of native mTomato+ bone marrow
(Figure 3C). eGFP+ cardiomyocytes were observed in the
hearts of both control and Gata4/6-deleted bone marrow recipients at the same level, which was attributable
to fusion because 100% of the cells were both eGFP+
and mTomato+ (Figure 3D and 3E). Furthermore, flow
cytometry analysis of cardiac interstitial cells revealed no
difference in total CD31+ cells (Figure 3F), demonstrating
that Gata4/6-deleted bone marrow alone did not recapitulate the phenotype of endothelial expansion or the
large relative increase in eGFP+ cardiomyocytes observed
in the standard Kit lineage–traced Gata4/6-deleted mice
at baseline.

Next, we performed a reverse bone marrow transplant strategy. Recipient KitMCM mice with or without
Gata4/6 deletion were lethally irradiated at 8 weeks
of age, whereafter they received control bone marrow
from global R26mT donors (Figure 3G). After 2 months
of tamoxifen treatment, mice were euthanized, and
cardiac sections were analyzed for mTomato+-traced
cardiomyocytes within Gata4/6 Kit lineage–deleted
hearts. The data show an ≈4-fold increase in bone
marrow–dependent mTomato+ cardiomyocytes with
endogenous Kit allele-dependent Gata4/6 deletion in
comparison with Gata4/6 wild-type controls, suggesting that it is the deletion of Gata4/6 within the existing
heart cells that leads to greater apparent cardiomyocyte
fusion/labeling (Figure 3H). It is important to note that
Kit-lineage endothelial cell recombination in bone marrow recipient mice was not significantly changed from
the ≈8% to 10% of total cardiac endothelium observed
in both control and Gata4/6-deleted hearts, with and
without bone marrow transplant (Figure 3I). Together,
these experiments demonstrate that a Kit lineage–de-

1016
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Figure 3. Increased cardiomyocyte cell fusion events occur with Kit lineage loss of Gata4/6 within heart cells during bone marrow transplant.
A, Experimental design for bone marrow transplant experiments examining the impact of Gata4/6 loss in Kit allele–derived bone marrow on cardiac phenotyping. B, Representative FACS plot showing recombination of eGFP+ bone marrow from a Kit allele lineage–traced donor mouse in a bone marrow transplant
recipient. C, Representative FACS plot showing effective irradiation and loss of native mTomato+ bone marrow in a recipient mouse. D, Representative eGFP+
mTomato+ fusion-derived cardiomyocyte from a cardiac histological section following bone marrow transplant. E, Percentage of Kit allele–dependent bone
marrow–derived eGFP+ cardiomyocytes from the entire heart of the indicated mice. Error bars are SEM, n=6 per group (10 sections per heart). F, Quantification of
cardiac CD31+ cells based on flow cytometry from the interstitial fraction in bone marrow transplant recipient hearts from the indicated mice. Error bars are SEM,
n=3 per group, P=n.s. G, Experimental design for bone marrow transplantation to examine the impact of endogenous cardiac loss of Gata4/6 in Kit allele–dependent lineages on the apparent rate of new cardiomyocytes and endothelial cells. H, Percentage of wild-type bone marrow–derived mTomato+ cardiomyocytes
within the entire heart following bone marrow transplant in the indicated mice. Error bars are SEM, n=6 per group (10 sections per heart), *P<0.05 vs. KitMCM
R26eGFP recipient. I, Quantification from cardiac sections of endogenous endothelial cell number from the Kit lineage with 2 months of tamoxifen induction, with
and without bone marrow transplantation, in the indicated mice. Error bars are SEM, n=3 per group, P=n.s. for all pairwise comparisons. BM indicates bone
marrow; BMT, bone marrow transplantation; eGFP, enhanced green fluorescent protein; FACS, fluorescence-activated cell sorting; n.s., nonspecific; SSC-A, side
scatter area; and Tam, tamoxifen.

rived cell source endogenous to the heart is the mechanistic basis for the increased ability of wild-type bone
marrow progenitor–derived cells (leukocytes) to fuse
with cardiomyocytes in vivo.
Endothelial cells are the predominant Kit lineage–
derived cell type present in the heart,22 suggesting
the hypothesis that loss of Gata4/6 within endogenous cardiac endothelial cells might be mechanistically responsible for greater immune cell infiltration
and fusion with cardiomyocytes. To test this hypothesis, we first attempted to alter the differentiation
and permeability characteristics of endogenous
cardiac endothelial cells by using VEGF-A. Previous
work has shown that VEGF-A overexpression leads
to weakening of endothelial junctions and increased
permeability as these cells partially dedifferentiate
or proliferate.41,42 Here, we used a VEGF-A adenoCirculation. 2018;138:1012–1024. DOI: 10.1161/CIRCULATIONAHA.118.033703

associated virus-9 to overexpress this factor in the
heart of Kit lineage–traced mice by tail vein injection (Figure IIA in the online-only Data Supplement).
VEGF-A overexpression in the heart (Figure IIB in the
online-only Data Supplement) produced a significant
increase in eGFP+ cardiomyocytes and leukocyte infiltration (Figure IIC through IIE in the online-only Data
Supplement), reminiscent of the increases observed
in Gata4/6-deleted mice.

Global Endothelial Deletion of Gata4
Despite the modest proportion of Kit allele–derived endothelium (≈10%), the loss of Gata4 in these cells of
the heart appeared to cause a global cardiac phenotype of endothelial cell expansion, leukocyte infiltration, and heterotypic cardiomyocyte fusion, suggesting
September 4, 2018
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that Kit allele–derived endothelial cells were critical in
adult vascular maintenance. To further implicate endothelial cells as the causative cell type, we used a tamoxifen-inducible Tie2 Cre-expressing transgenic mouse
(Tie2CreERT2) to achieve a global and adult endothelial
cell–specific deletion of Gata4. Tie2 lineage–traced
mice were used as controls versus lineage-traced Gata4-deleted mice with a continuous tamoxifen regimen,
again beginning after weaning (Figure 4A and 4B). It is
remarkable that after 2 months of tamoxifen, Gata4deleted endothelial cells showed a ≈2-fold increase
in Tie2-eGFP+ in the heart (Figure 4C and 4D) with a
significant shift from CD31 high-expressing to CD31
low-expressing cells by flow cytometry (Figure 4G and
4H), suggesting a less differentiated state. Adult endothelial cell–specific deletion of Gata4 also resulted in
the greater presence of CD45+ cells in the heart (Figure 4E and 4F). In addition, 5-ethynyl-2ʹ-deoxyuridine
staining of cardiac sections showed a 3-fold increase in
A

endothelial cell–specific proliferation (Figure 4I). Skeletal muscle showed similar results with a shift toward
CD31 low-expressing cells and increased 5-ethynyl-2ʹdeoxyuridine staining (Figure IIIA and IIIB in the onlineonly Data Supplement). Together, these data suggest
that loss of Gata4 in adult endothelial cells alters their
differentiated state and produces greater proliferation
and leukocyte diapedesis.
To probe even further into the hypothesis that deletion of Gata4 from Kit allele lineage–derived endothelial cells is the primary reason for enhanced bone
marrow–derived leukocyte fusion with endogenous
cardiomyocytes, we used the KitMCM allele together
with the Tie2CreERT2 transgene in Gata4fl/fl R26eGFP mice
given continuous tamoxifen (Figure 5A and 5B). Unfortunately, the Tie2CreERT2 transgene is not active in
bone marrow; hence, the KitMCM allele is needed to
label fusigenic immune cells, even though both Cre
alleles would inactivate Gata4 within endothelial cells

Downloaded from http://ahajournals.org by on January 12, 2022

C

D

E

F

B

G

H

I

Figure 4. Global Tie2-lineage deletion of Gata4 expands the immature endothelial cell population and increases diapedesis.
A, Genetic models with the indicated alleles or transgenes in mice that were crossed. B, Experimental design of the protocol used in this figure. The Tie2 promoter
from the Tek gene was used to drive the Cre-ERT2 cDNA. C, Representative cardiac histological sections showing Tie2 lineage–traced eGFP+ cells (green) from the indicated genotypes of mice. D, Quantification of Tie2 lineage–traced eGFP+ endothelial cells by flow cytometry from the interstitial fraction in hearts of the indicated
lines of mice. Error bars are SEM, n=3 per group, *P<0.05 vs. Tie2CreERT2 R26eGFP. E, Representative cardiac histological sections showing CD45+ cells (white) and DAPI
(blue) from the indicated genotypes of mice. F, Quantification of CD45+ cells by flow cytometry of the interstitial fraction in the hearts of the indicated lines of mice.
Error bars are SEM, n=3 per group, *P<0.05 vs. Tie2CreERT2 R26eGFP. G, Flow cytometry plots showing cardiac CD31+ cells with gating to display low- and high-expressing cells from the indicated genotypes of mice. H, Quantification of CD31low, CD31high, and total CD31+ cells from flow cytometry of the interstitial fraction of hearts
of the indicated genotypes of mice. Error bars are SEM, n=3 per group, P=0.0257 for CD31 low comparison, P=0.1799 for CD31 high comparison, and P<0.0001
for total CD31+ comparison vs. Tie2CreERT2 R26eGFP. I, Quantification of EdU+ nuclei in Tie2 lineage-traced eGFP+ cardiac endothelial cells from cardiac histological
sections from the indicated genotypes of mice. Error bars are SEM, n=3 per group (6 EdU-stained sections per heart). *P<0.05 vs. Tie2CreERT2 R26eGFP. DAPI indicates
4ʹ,6-diamidino-2-phenylindole; EdU, 5-ethynyl-2ʹ-deoxyuridine; eGFP, enhanced green fluorescent protein; SSC-A, side scatter area; and Tam, tamoxifen.
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Figure 5. Global Tie2-lineage deletion of Gata4 augments appearance of Kit lineage– and bone marrow–labeled cardiomyocytes.
A, Genetic models with the indicated alleles or transgenes in mice that were crossed. B, Experimental design of the protocol used in this figure. The Tie2 promoter
from the Tek gene was used to drive the Cre-ERT2 cDNA. C, Whole-mount imaging of tibias from mice of the indicated genotypes of mice, highlighting labeled
bone marrow cells (green) when the Kit lineage–tracing allele was used. D, Representative image showing accumulation of Kit allele–derived eGFP+ cardiomyocytes (arrowheads) in cardiac histological sections from the indicated mouse genotype 2 months after Gata4 deletion. E, Quantification of eGFP+ cardiomyocytes
from KitMCM lineage tracing and KitMCM Tie2CreERT2 dual lineage tracing, with or without Gata4 deletion. Error bars are SEM, n=4 per group. *P<0.001 vs. KitMCM
R26eGFP controls by 2-way ANOVA. #P<0.001 vs. dual KitMCM Tie2CreERT2 R26eGFP by 2-way ANOVA. F, Experimental design for bone marrow transplant of wild-type
mTomato+ bone marrow into Tie2CreERT2 recipient mice with or without Gata4 deletion. G, Representative cardiac histological image of an mTomato+ cardiomyocyte
(arrowhead) derived from bone marrow following bone marrow transplant from the mice shown in F. H, Quantification of mTomato+ cardiomyocytes from cardiac
histological sections of recipient mice of the indicated genotypes following bone marrow transplant. Error bars are SEM, n=6 per group (10 sections per heart).
*P<0.05 vs. Tie2CreERT2 R26eGFP recipient mice. eGFP indicates enhanced green fluorescent protein; and Tam, tamoxifen.

of the heart (Figure 5C). The data again showed significantly greater rates of eGFP+-fused cardiomyocytes with KitMCM allele–mediated deletion of Gata4,
and that enhanced deletion of Gata4 from essentially
all endogenous cardiac endothelial cells with the
Tie2CreERT2 transgene doubled the number of fused cardiomyocytes (Figure 5D and 5E). To show this even
more conclusively, bone marrow transplantation
was performed between a R26mT donor mouse and
a Tie2CreERT2 Gata4fl/fl R26eGFP recipient mouse. In this
manner, the recipient mice only have Tie2CreERT2 causing Gata4 deletion in adult endothelial cells without
deletion of Gata4 from bone marrow–derived immune
cells or endothelial progenitors. The data again show
an enhanced rate of mTomato+-fused cardiomyocytes,
indicating that the effect is exclusively attributable to
defects within endogenous endothelial cells of the
heart when Gata4 is deleted (Figure 5G and 5H).
Circulation. 2018;138:1012–1024. DOI: 10.1161/CIRCULATIONAHA.118.033703

Ex Vivo and Developmental Analysis of
Gata4-Deleted Endothelial Cells
Isolation and culturing of endothelial cells from these
genetically modified mouse hearts grossly showed that
Gata4-replete cells form a typical cobblestone monolayer, whereas Gata4-deleted cells are less adherent
and show a more torturous morphology (Figure 6A).
Analysis of cell culture supernatant showed an increase
in secretion of angiopoietin-2 and decreased VEGF-A
from Gata4-deleted endothelial cells, which suggests a
vascular-regressive state (Figure 6B and 6C).43,44 Endothelial cells mixed with Matrigel from these mice were
subcutaneously injected into wild-type recipient mice to
evaluate vascular tube formation with or without Gata4
deletion (Figure 6D). After 2 weeks, Matrigel plugs were
collected and analyzed by confocal microscopy, which
showed a limited ability of Gata4-deleted endothelial
September 4, 2018
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Figure 6. Gata4-deleted endothelial cells demonstrate poor differentiation and impaired tube formation.
A, eGFP-based imaging of cardiac endothelial cells grown in culture after isolation by fluorescence-activated cell sorting of Tie2-eGFP+ CD31+ cells from the indicated
genotypes of mice. n=3 per group (12 wells of 10 000 cells per heart). Angiopoeitin-2 (B) and VEGF-A protein (C) quantification from the collected supernatants
of cardiac endothelial cell cultures as described in A. Error bars are SEM, n=3 per group (3 replicates each). *P<0.05 vs. Tie2CreERT2 R26eGFP at each time point. D,
Experimental design for ex vivo Matrigel angiogenesis assay from the indicated genotypes of mice over the 2-week time period. E, Representative images of tube
formation from harvested Matrigel plugs (images presented as flattened z-stack) from the indicated genotypes of mice. The bottom 2 panels are enlarged versions of
the smaller windows shown in the top 2 panels. n=4 per group. F, Pictures of whole-mount embryos from constitutive KitCre expressing mice demonstrating hemorrhagic phenotype with Gata4 deletion, but not in control embryos at embryonic day (E) 11.5 of development. n=4. The arrowheads show areas of hemorrhage. G,
Experimental design for the retinal angiogenesis assay from neonatal times of postnatal day 0 through postnatal day 8. H, Representative whole-mount images of
postnatal day 8 hearts from control and Tie2CreERT2 Gata4-deleted hearts. I, Representative whole-mount images of neonatal retinas with eGFP imaging based on
Tie2CreERT2 lineage tracing. The genotypes of mice used are shown, and the bottom 2 panels are higher magnification images of the upper 2 panels. n=6 per group.
Angpt-2 indicates angiopoeitin-2; eGFP, enhanced green fluorescent protein; TAM, tamoxifen; and VEGF-A, vascular endothelial growth factor-A.

cells to form differentiated vascular networks in comparison with Gata4-replete cells using z-stacked confocal microscopy (Figure 6E).
Previously, embryonic endothelial-specific deletion of
Gata4 with a constitutive Tie2-Cre transgene demonstrated late embryonic or perinatal lethality because of
defective epithelial-to-mesenchymal transition and improper heart valve formation.45 Here, we also observed
embryonic lethality with a constitutive KitCre allele to delete Gata4. More specifically, constitutive KitCre Gata4fl/fl
mice were found to be hemorrhagic at embryonic day
11.5 with noticeable areas of blood pooling and defective vasculogenesis, leading to embryonic lethality
(Figure 6F). Constitutive Cdh5Cre (endothelial cell–specific cadherin 5 gene promoter)–mediated deletion of
Gata4 also produced embryonic lethality at the same
time (data not shown). Taken together, these results

suggest that Kit allele–derived cells critically underlie
early hemangioblast progenitor cell activity during development and that Gata4 is essential in these cells for
proper vascular development.
Development of the superficial vascular plexus in
the neonatal mouse eye begins at birth, with radial
outgrowth of endothelial vessels reaching the retinal
edge by p8.46 To test the role of Gata4 in retinal vascularization, Tie2-dependent lineage-traced mice were
injected with tamoxifen at p0 and harvested at p8 for
cardiac phenotyping and retinal angiogenesis (Figure 6G). Tie2CreERT2 Gata4fl/fl mice were underdeveloped
in comparison with Gata4fl/fl controls with significantly
reduced heart size (Figure 6H) and improper patterning
of both micro- and macrovasculature in the retina in
comparison with Tie2CreERT2 R26eGFP controls (Figure 6I).
Together, these findings suggest that, in addition to
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Gene Expression Alterations in Adult
Gata4-Deficient Endothelial Cells
To elucidate the molecular basis for Gata4-dependent
regulation of endothelial cell differentiation, global RNA
sequencing was performed from cardiac endothelial
cells isolated from Tie2CreERT2 R26eGFP Gata4fl/fl mice versus Tie2CreERT2 R26eGFP controls (Figure 7). Cells doublepositive for endogenous Tie2 lineage tracing (eGFP+)
and fluorescently labeled for CD31 were obtained by
fluorescence-activated cell sorting at 8 weeks of age
after 4 weeks of tamoxifen induction. Bioinformatics
analysis of the data showed a gene expression signature in which many of the top categories are related to
previously known partners and targets of Gata4, and
genes related to the function and maintenance of the
vasculature (Figure 7). Although signature endothelialdefining genes47 (Cdh5, Edn1, Kdr, Pecam1, S1pr1,
Vwf) were largely unchanged, well-established regulatory partners of Gata4, including Fog2 (Zfpm2),48,49
Hand2,50 Tbx20,51 Dkk3,52 Mlc2a (Mly7),53 Sox9,54 and
Klf15,55 were significantly downregulated. A variety of
putatively Gata4-regulated genes were also identified

using the Harmonizome database,56 many of which
have evidence for vascular regulation. For example, Figf
(Vegfd), a predicted target of Gata4, was downregulated in this study and has a known role in endothelial
cell regulation.57 A host of genes related in angiogenesis and extracellular matrix formation were impacted
with Gata4 deletion including downregulation of Itgb4,
Mmp2, Timp2, Vcam1, and Vcan and upregulation of
Apold1 and Has3 (Figure 7). In addition, a number of
genes related to the cell cycle in endothelial cells were
upregulated, such as E2f7, Egr1/2/3, Esm1, and Plk3.
Verification of mRNA expression differences was performed for most of these gene changes by quantitative reverse transcription polymerase chain reaction,
showing consistency with the patterns found by RNA
sequencing analysis (Figure IV in the online-only Data
Supplement). Together, these gene expression data
suggest a global impact of Gata4 deletion on the endothelial cell differentiation gene program, helping to
validate the observed differences in proliferation, permeability, and maturation.

DISCUSSION
Here, we used a genetic approach to determine if the
very low level of presumed new cardiomyocyte generation in the heart from the Kit lineage really occurs, es-

Downloaded from http://ahajournals.org by on January 12, 2022
Figure 7. Gata4-deleted adult cardiac endothelial cells have dysregulation of cell cycle and angiogenesis-related genes.
RNA sequencing analysis of selected genes from sorted Tie2 lineage–traced eGFP+ CD31+ cells from hearts of adult mice with or without Gata4 deletion mediated
by the Tie2CreERT2 transgene (4 weeks of tamoxifen). Data show fold change in mRNA between Gata4-deleted and wild-type endothelial cells, and are organized to
highlight genes relevant to previously defined endothelial gene sets or those known to interact with the transcription factor Gata4. n=2 per group (2 combined
digested hearts each). See Methods in the online-only Data Supplement for description of bioinformatics and by DESeq2 analysis to show genes differentially expressed. *P<0.05 vs. WT endothelial cells. Eight of the mRNAs shown were not statistically significant by DESeq2 but are included because they were significantly
changed by RT-PCR (see Figure IV in the online-only Data Supplement). ECM indicates extracellular matrix; eGFP, enhanced green fluorescent protein; RT-PCR,
reverse transcriptase polymerase chain reaction; and WT, wild type.
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pecially because it was recently reported that adult cardiac Kit-dependent CPCs never truly transdifferentiate
into cardiomyocytes.24 Indeed, deletion of Gata4 and
Gata6 simultaneously from Kit lineage cells did not reduce the apparent rate of cardiomyocyte labeling in the
heart by genetic lineage tracing, and in fact caused as
much as a 10-fold increase. Because Gata4/6 are lacking, it is even more unlikely that new cardiomyocytes
could be created from a progenitor cell source, even
embryonic stem cells.27 This consideration, along with
the very dramatic increase in cell fusion we observed in
the current study, suggest that most past results reporting a minor contribution of cardiomyocytes from the
Kit lineage are likely because of cellular fusion between
lineage-traced immune cells and host endogenous cardiomyocytes, or from ectopic induction of the KitMCM allele in cardiomyocytes.24 Indeed, our past results, which
were subtracted for cellular fusion effects, still showed
apparent de novo cardiomyocyte production at ≈1 in
17 000, but, as suggested in the recent literature, this
likely reflects ectopic activation of the KitCre allele within
rare cardiomyocytes.24,58 Hence, it could be argued that
Kit lineage–traced cells from any source, whether bone
marrow or endogenous to the heart, essentially lack all
cardiomyocyte transdifferentiation ability.
In attempting to understand how Gata4 deletion
from the Kit lineage produced an apparent 10-fold
increase in eGFP+ cardiomyocytes, we uncovered an
essential role for this transcription factor in regulating the endothelial cell gene program. Although endothelial cell–specific deletion of Gata4 was shown to
cause developmental lethality because of alterations
in endothelial cell activity in the cardiac cushions and
newly developing heart valves,45 a role for Gata4 in
adult cardiac vascular maintenance had not been previously explored. Gata4 was also recently identified as
a master regulator of liver sinusoidal endothelial cells,
determining their organ specificity and requirement in
liver development.59 In addition, in this transition from
sinusoidal to capillary formed vascular networks in the
liver, the authors observed a distinct shift in CD31low
cells to CD31high cells.59 Conversely, we observed a shift
toward more permeable vasculature and greater CD31low cells (less differentiated) in the heart and skeletal
muscle with deletion of Gata4, but this effect was not
observed in the liver or lung of our study using Tie2CreERT2
(data not shown).
We observed that Gata6 deletion in both Kit allele
and endothelial lineages did not overtly alter the angiogenic and vascular processes as shown with Gata4
deletion. Indeed, we observed that constitutive KitCreexpressing Gata6fl/fl-deleted mice were not lethal and,
when lineage-traced through development to 5 months
of age, did not show increases in eGFP+ cardiomyocytes.
Endothelial cell–specific deletion of Gata6 with the inducible Tie2-specific Cre mice also did not demonstrate

an increase in CD31+ cells or increased vascular permeability, suggesting that only Gata4 plays a specific role
in regulating the expression of genes involved in endothelial cell biology. We previously observed a similar
paradigm at the level of the cardiomyocyte in which
angiogenic genes in this cell type were preferentially
regulated by Gata4 over Gata6.29
Currently, we speculate that Gata4 is important in
endothelial cell maturation/differentiation largely because of the observed ex vivo defective tube formation and the appearance of CD31low endothelial cells
in Tie2CreERT2 transgene-mediated Gata4-deleted mice.
The overall increase in CD31+ and Tie2 lineage–traced
eGFP+ cells could be a compensatory response of the
cardiac vasculature because of the inability of endothelial cells to maintain secure junctions when Gata4regulated gene expression is compromised. Thus, new
endothelial cells are formed as an attempt to bolster
the vasculature, yet leukocytes are still able to infiltrate more easily, giving greater fusion events with endogenous cardiomyocytes. Alternatively, poorly differentiated endothelial cells resulting from the deletion
of Gata4 generate a tissue injury–like signal in these
cells that recruits leukocytes and makes them more
active. Overall, our results suggest that Gata4 could
be used as a therapeutic leverage point in affecting
endothelial cell biology for selective therapeutic approaches in humans.
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